ASPHALION | UKRP INFOGRAPHIC

Beginning a requirement for device registration and the introduction of the device in the United Kingdom, as of January 1st, 2021, medical device manufacturers from outside of the United Kingdom and without any local business operations must designate a United Kingdom Responsible Person (UKRP) on their behalf.

Beginning a requirement for device registration and the introduction of the device in the United Kingdom, as of January 1st, 2021, medical device manufacturers from outside of the United Kingdom and without any local business operations must designate a United Kingdom Responsible Person (UKRP) on their behalf.
August 9, 2021

➡️ Since January 1st, 2021, Medical Device manufacturers located outside the United Kingdom and without any local business offices shall appoint a United Kingdom Responsible Person (UKRP), on their behalf, as a pre-requisite for device registration and launch of the device in the United Kingdom. The UKRP acts as the point of contact between a manufacturer located outside the UK and the UK´s Medicines and Healthcare products Regulatory Agency (MHRA).

➡️ Have a look at the infographic we have prepared that summarizes the Medical Devices legal framework in UK after BREXIT, as well as the responsibilities of the UK Responisble Person and how Asphalion can help you, through its office in London, acting as your UKRP, fulfilling all obligations and keeping your Regulatory interests up to date. We have already started delivering this service to our customers and can help you along the way.

☑️ In case you would like to know more about this service, you can contact us at:

📧  [email protected]

👀 UKRP Infographic ⬇️

 

Search News & Events

  • Filter by category

Share

Related news and events

EVENTS | Asphalion present at Key events this year

At Asphalion, we’re excited to be part of key events, conferences, and summits throughout 2026—great opportunities to connect, exchange insights, and collaborate with leaders across healthcare and medical devices. 

EVENT | DIA Europe

DIA Europe 2026 will take place in Rotterdam from 24–26 March 2026. As Europe’s largest neutral conference in the life sciences sector, it will gather 1,500 professionals from over 50 countries for three days of exchange and collaboration. The programme features 10 dynamic tracks covering key areas such as Clinical Trials Innovation, AI & Real-World Evidence, Innovative Therapies, Medical Devices, and Pharmacovigilance, alongside 80+ sessions and contributions from 300+ experts, regulatory authorities, HTA bodies, payers, and patient organizations—offering a key platform to drive innovation and informed decision-making in healthcare.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting